CDK11 Media la autofagia para promover la proliferación y migración de las células de cáncer de mama mediante la regulación de BCL-2
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.La inhibición de la cinasa 11 dependiente de la ciclina (CDK11) suprime el crecimiento de las células de cáncer de mama mediante la inducción de la autofagia. Este proceso, regulado por BCL-2, sugiere CDK11 como un objetivo terapéutico potencial para el tratamiento del cáncer de mama.
Área De La Ciencia
- Biología molecular
- Investigación del cáncer
- Biología celular
Sus Antecedentes
- La cinasa 11 dependiente de la ciclina (CDK11) está sobreexpresada en el cáncer de mama, lo que se correlaciona con malos resultados.
- Los mecanismos precisos de la CDK11 en la progresión del cáncer de mama no se comprenden completamente.
Objetivo Del Estudio
- Investigar el papel de CDK11 en la proliferación, migración y autofagia del cáncer de mama.
- Para aclarar los mecanismos reguladores que involucran a CDK11, la autofagia y BCL-2 en el cáncer de mama.
Principales Métodos
- Inhibición de la CDK11 y eliminación de las células de cáncer de mama.
- Inhibición de la autofagia mediante cloroquina (CQ) y reducción de la ATG7.
- Perfiles de expresión génica y estudios de sobreexpresión de BCL-2.
- Estudios in vivo con un modelo de tumor xenograft subcutáneo en ratón.
Principales Resultados
- La inhibición de CDK11 suprimió la proliferación y migración de las células de cáncer de mama mientras inducía la autofagia.
- El bloqueo de la autofagia revirtió los efectos inhibidores de la reducción de la CDK11.
- La knockdown de CDK11 desreguló el factor antiapoptótico BCL-2.
- La sobreexpresión de BCL-2 salvó parcialmente la autofagia y revirtió la inhibición de la proliferación/migración.
- In vivo, la sobreexpresión de BCL-2 rescató parcialmente la inhibición del crecimiento tumoral causada por el bloqueo de CDK11.
Conclusiones
- La inhibición de CDK11 induce la autofagia, que a su vez suprime la proliferación y migración de las células de cáncer de mama.
- CDK11 media la autofagia para promover la progresión del cáncer de mama, con BCL-2 jugando un papel regulador clave.
- CDK11 representa un objetivo terapéutico prometedor para el cáncer de mama humano.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...